OAM
BMRN icon

OP Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

OP Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.17M Buy
+56,060
New +$3.27M 0.03% 342
2025
Q4 		– Sell
-22,635
Closed -$1.23M – 784
2025
Q3 		$1.23M Hold
22,635
– – 0.02% 569
2025
Q2 		$1.24M Buy
22,635
+2,127
+10% +$125K 0.02% 571
2025
Q1 		$1.45M Buy
+20,508
New +$1.38M 0.02% 521

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OP Asset Management's BMRN Position: Q1 2026 in Review

OP Asset Management opened a new position in BioMarin Pharmaceuticals (BMRN) in Q1 2026: 56,060 shares worth $3.17M. The stake represents 0.03% of the portfolio and ranks #342 among its holdings. This is a return to the name: OP Asset Management previously reported a position in BMRN as recently as Q3 2025.

OP Asset Management first reported a position in BMRN in Q1 2025 and has held it in 4 quarters since. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • OP Asset Management held 56,060 shares of BioMarin Pharmaceuticals worth $3.17M as of Q1 2026.
  • BioMarin Pharmaceuticals was a new OP Asset Management position in Q1 2026.
  • BioMarin Pharmaceuticals made up 0.03% of OP Asset Management's portfolio in Q1 2026, its #342 holding.
  • OP Asset Management first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.